Subscribe To
Better big biotech buy: vertex vs. biogen
Vertex Pharmaceuticals is heading for a big moment -- a regulatory decision on a potential new blockbuster. Biogen recently won regulatory approval fo...
July 24, 2023, 10:09 am
Bitcoin price prediction: bybit ceo discusses regulatory outlook and market trends
In cryptocurrency’s ever-evolving landscape, Bitcoin’s price continues to capture attention as it trades at $29,723, experiencing a slight decreas...
July 24, 2023, 8:29 am
China securities regulator met with global firms to hear concerns about investing in china
Hong Kong press with the report about China Securities Regulatory Commission vice-chairman Fang Xinghai meeting with some global venture capital and p...
July 23, 2023, 10:31 pm
Aussie competition regulator delays decision on anz's $3.3 bln suncorp bank buy
Australia's competition regulator on Monday said it has delayed its decision on ANZ Group Holdings' pro...
July 23, 2023, 10:12 pm
Oneok - buying for the dividend and the growth
ONEOK Inc is set to become one of the largest energy infrastructure companies in the US following its acquisition of Magellan Midstream Partners, a de...
July 22, 2023, 8:56 am
Fortive: cheap, impressive outlook, and ambitious m&a strategy
Fortive Corporation expects a positive outlook for 2023 with impressive EPS and FCF growth expectations from 2023 to 2025, potentially through further...
July 22, 2023, 4:52 am
Us sec’s spot bitcoin etf approval would have a global impact, market awaits regulator’s decision
BlackRock’s Bitcoin spot ETF has 50-50 chance of being approved by the US SEC following the company’s refiling, according to a Bloomberg Intellige...
July 21, 2023, 6:59 pm
Best cannabis & marijuana stocks for 2023
Now is a volatile time to invest in top marijuana stocks. If you plan and strategize correctly can potentially make you some money. Currently, the can...
July 21, 2023, 12:00 pm
Us regulator backs off microsoft-activision challenge
The US Federal Trade Commission is suspending its attempt to block Microsoft's buyout of video gaming giant Activision Blizzard, a legal filing showed...
July 21, 2023, 11:45 am
Weekly news summary for july 14 to july 20
Weekly News Summary for July 14 to July 20 Friday: July 14: China Invites Global Investors amid Economy Issues Financial regulators from China invited...
July 21, 2023, 10:42 am
Consob's fight against financial fraud: 4 websites blocked in latest offensive
The Italian financial market regulator, Consob, has continued its actions against illegal financial services platforms with the latest blacklist of fo...
July 21, 2023, 9:56 am
Trump-linked spac surges as fraud settlement lifts hopes for deal completion
Shares of Digital World Acquisition (DWAC) surged 20% in premarket trading on Friday as a settlement with U.S. securities ...
July 21, 2023, 8:32 am
Eu health regulator backs pfizer's rsv vaccine for infants, older adults
The European Union's health regulator on Friday backed authorization of Pfizer's vaccine for respirator...
July 21, 2023, 8:12 am
Mirati therapeutics shares fall after lung cancer drug gets negative opinion from european regulators
Shares of Mirati Therapeutics Inc. MRTX, -2.40% were down 4.7% premarket on Friday after the company said the European Medicines Agency had issued a n...
July 21, 2023, 8:06 am
How cyprus, germany, and sweden command 75% of eu's cross-border retail trading
The European Securities and Markets Authority (ESMA) and National Competent Authorities (NCAs) recently completed an analysis of cross-border investme...
July 21, 2023, 7:33 am
Blazing opportunities: top marijuana stocks to watch on end of july
As the cannabis industry and top marijuana stocks continue to rise, 2023 is an excellent opportunity for investors and traders to enter the thriving w...
July 21, 2023, 7:30 am
Microsoft-activision deal gets a boost from the ftc. u.k. regulator still holds out.
Microsoft's $69 billion deal of Activision Blizzard is inching closer as the FTC pauses its in-house case but the U.K. ...
July 21, 2023, 6:28 am
Eu regulator declines to back mirati's lung cancer drug
Mirati Therapeutics said on Friday the European regulator's panel for medical products has declined to recommend an authorization for the company's dr...
July 21, 2023, 6:22 am
Where will nano-x imaging be in 3 years?
Nano-X now has approval from regulators in the U.S. to market its unique X-ray device. It'll be placing its systems mostly in places where there are f...
July 21, 2023, 5:35 am
Is now a good time to buy crispr therapeutics?
CRISPR Therapeutics expects regulatory decisions soon for what would be its first commercialized product. An approval would represent a vote of confid...
July 21, 2023, 5:30 am